Ann E. Taylor

发表

Clinical Evaluation of Polycystic Ovary Syndrome

Ann E. Taylor, A. Taylor, 2007 .

ANDROGEN EXCESS SOCIETY GUIDELINE SYNDROME AS A PREDOMINANTLY HYPERANDROGENIC SYNDROME: AN POSITION STATEMENT: CRITERIA FOR DEFINING POLYCYSTIC OVARY

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2006 .

A Putative Relationship between Valproic Acid and Polycystic Ovarian Syndrome: Implications for Treatment of Women with Seizure and Bipolar Disorders

R. Baldessarini, L. Cohen, Janet E Hall, 2003, Harvard review of psychiatry.

Follistatin Physiology and Potential Mechanisms of Action in the Human

W. Crowley, P. Sluss, F. Pralong, 1997 .

A Clinical Guide for Contraception

Ann E. Taylor, 1993 .

Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.

C. Welt, Janet E Hall, K. Martin, 2002, The Journal of clinical endocrinology and metabolism.

Effects of short‐term hormone replacement on serum leptin levels in postmenopausal women

J. L. Sharpless, E. Anderson, Ann E. Taylor, 1999, Clinical endocrinology.

Clinical Pharmacology of Multiple Doses of Lasofoxifene in Postmenopausal Women

M. Gardner, A. Milton, B. Duncan, 2006, Journal of clinical pharmacology.

Systemic adversities of ovarian failure.

Ann E. Taylor, A. Taylor, 2001 .

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2009, Fertility and sterility.

Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2006, The Journal of clinical endocrinology and metabolism.

Exaggerated Free α-Subunit Levels during Pulsatile Gonadotropin-Releasing Hormone Replacement in Women with Idiopathic Hypogonadotropic Hypogonadism1

W. Crowley, K. Martin, Ann E. Taylor, 1998 .

Use of the Free Alpha Subunit (FAS) of Glycoprotein Secreting Hormones as a Surrogate Marker of GnRH Secretion in the Human

W. Crowley, J. Finkelstein, K. Martin, 1994 .

New Approaches to the Study of the Neuroendocrine Abnormalities of Women with the Polycystic Ovarian Syndrome a

W. Crowley, K. Martin, Ann E. Taylor, 1993, Annals of the New York Academy of Sciences.

Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy

M. Dam, M. Morrell, J. Messenheimer, 2003, Epilepsy Research.

On the Association Between Valproate and Polycystic Ovary Syndrome

B. Pedersen, P. Genton, M. Sauer, 2001, Epilepsia.

Systemic Adversities of Ovarian Failure

Ann E. Taylor, A. Taylor, 2001, Journal of the Society for Gynecologic Investigation.

Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men

F. Greenway, Steven R Smith, D. Fryburg, 2010, Obesity.

Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

C. Welt, A. Schneyer, J. Adams, 2005, The Journal of clinical endocrinology and metabolism.

Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.

W. Crowley, J. Adams, Ann E. Taylor, 2004, The Journal of clinical endocrinology and metabolism.

Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure.

C. Welt, J. Adams, Ann E. Taylor, 2005, The Journal of clinical endocrinology and metabolism.

Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels.

C. Welt, K. Martin, A. Falorni, 2005, The Journal of clinical endocrinology and metabolism.

Effects of Steady-State Lasofoxifene on Cyp2D6- and Cyp2E1-Mediated Metabolism

R. Obach, R. Walsky, M. Gardner, 2006, The Annals of pharmacotherapy.

Lack of effect of short-term diazoxide administration on luteinizing hormone secretion in women with polycystic ovary syndrome.

Michael L. Johnson, W. Evans, J. Nestler, 2007, Fertility and sterility.

Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.

D. Schoenfeld, J. Hall, J. Adams, 1997, The Journal of clinical endocrinology and metabolism.

Gonadotropin dysfunction in women with polycystic ovary syndrome.

Ann E. Taylor, 2006, Fertility and sterility.

Polycystic ovary syndrome.

A. Taylor, Ann E. Taylor, A. Taylor, 1998, Endocrinology and metabolism clinics of North America.